IVF — INVO Fertility, Inc.

INVO Fertility, Inc. is a profitable enterprise primarily focused on delivering fertility services. Beyond this core business, the company actively develops clinical-stage therapies targeting oncology and autoimmune disorders. The firm was established on January 5, 2007, and its operations are based in Sarasota, Florida.

Company profile

• Sector: Healthcare
• Industry: Medical - Devices
• Country: US
• Exchange: NASDAQ Capital Market
• Employees: 30
• Website: https://www.invofertility.com

Latest SEC filings for IVF

• SCHEDULE 13G/A — 2026-10-09
• S-8 — 2026-08-28
• EFFECT — 2026-08-05
• S-1 — 2026-07-24
• 8-K — 2026-06-02
• 10-K — 2026-06-02
• 8-K — 2026-06-02
• NT 10-Q — 2026-05-18
• 8-K — 2026-04-29
• SCHEDULE 13G — 2026-04-01

Latest IVF news

• 2026-09-25 — INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

Abrir análisis completo

Educational tool only — not investment advice.